These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14534609)

  • 1. Content of autoantibodies to bradykinin and beta-amyloid(1-42) as a criterion for biochemical differences between Alzheimer's dementias.
    Myagkova MA; Gavrilova SI; Lermontova NN; Kalyn YB; Selezneva ND; Zharikov GA; Kolykhalov IV; Abramenko TV; Serkova TP; Bachurin SO
    Bull Exp Biol Med; 2003 Jul; 136(1):49-52. PubMed ID: 14534609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to beta-amyloid and neurotransmitters in patients with Alzheimer's disease and senile dementia of the Alzheimer type.
    Myagkova MA; Gavrilova SI; Lermontova NN; Kalyn YB; Selezneva ND; Zharikov GA; Kolykhalov IV; Abramenko TV; Serkova TP; Bachurin SO
    Bull Exp Biol Med; 2001 Feb; 131(2):127-9. PubMed ID: 11391392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias.
    Maetzler W; Berg D; Synofzik M; Brockmann K; Godau J; Melms A; Gasser T; Hörnig S; Langkamp M
    J Alzheimers Dis; 2011; 26(1):171-9. PubMed ID: 21593566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the binding mechanism of Alzheimer's Aβ1-42 to nicotinic acetylcholine receptors based on similarity with snake α-neurotoxins.
    Maatuk N; Samson AO
    Neurotoxicology; 2013 Jan; 34():236-42. PubMed ID: 23022323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between naturally occurring anti-amyloid β autoantibodies and medial temporal lobe atrophy in Alzheimer's disease.
    Kimura A; Takemura M; Saito K; Yoshikura N; Hayashi Y; Inuzuka T
    J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):126-131. PubMed ID: 27330118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased serum amyloid beta(1-42) autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid beta(1-42) peptide.
    Brettschneider S; Morgenthaler NG; Teipel SJ; Fischer-Schulz C; Bürger K; Dodel R; Du Y; Möller HJ; Bergmann A; Hampel H
    Biol Psychiatry; 2005 Apr; 57(7):813-6. PubMed ID: 15820240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure inducing ionic liquids-enhancement of alpha helicity in the Abeta(1-40) peptide from Alzheimer's disease.
    Debeljuh N; Barrow CJ; Henderson L; Byrne N
    Chem Commun (Camb); 2011 Jun; 47(22):6371-3. PubMed ID: 21547327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.
    Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE
    Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular structure of a fibrillar Alzheimer's A beta fragment.
    Serpell LC; Blake CC; Fraser PE
    Biochemistry; 2000 Oct; 39(43):13269-75. PubMed ID: 11052680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Terminal Hypothesis for Alzheimer's Disease.
    Murray B; Sharma B; Belfort G
    ACS Chem Neurosci; 2017 Mar; 8(3):432-434. PubMed ID: 28186729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's Amyloid-β Sequesters Caspase-3 in Vitro via Its C-Terminal Tail.
    Chang YJ; Linh NH; Shih YH; Yu HM; Li MS; Chen YR
    ACS Chem Neurosci; 2016 Aug; 7(8):1097-106. PubMed ID: 27227450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of the carboxyl terminus of the Alzheimer Abeta peptide on its conformation, aggregation, and neurotoxic properties.
    Soreghan B; Pike C; Kayed R; Tian W; Milton S; Cotman C; Glabe CG
    Neuromolecular Med; 2002; 1(1):81-94. PubMed ID: 12025818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Alzheimer's disease peptide β-amyloid promotes thrombin generation through activation of coagulation factor XII.
    Zamolodchikov D; Renné T; Strickland S
    J Thromb Haemost; 2016 May; 14(5):995-1007. PubMed ID: 26613657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibody-catalyzed hydrolysis of amyloid beta peptide.
    Taguchi H; Planque S; Nishiyama Y; Symersky J; Boivin S; Szabo P; Friedland RP; Ramsland PA; Edmundson AB; Weksler ME; Paul S
    J Biol Chem; 2008 Feb; 283(8):4714-22. PubMed ID: 18086674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and characterization of the amyloid β40 dimer model with a linker at position 30 adjacent to the intermolecular β-sheet region.
    Murakami K; Suzuki T; Hanaki M; Monobe Y; Akagi K; Irie K
    Biochem Biophys Res Commun; 2015 Oct; 466(3):463-7. PubMed ID: 26367176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry.
    Portelius E; Lashley T; Westerlund A; Persson R; Fox NC; Blennow K; Revesz T; Zetterberg H
    Neurodegener Dis; 2015; 15(1):50-7. PubMed ID: 25591542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune responses to amyloid structures of Abeta(25-35) peptide and human lysozyme in the serum of patients with progressive Alzheimer's disease.
    Gruden MA; Davudova TB; Malisauskas M; Zamotin VV; Sewell RD; Voskresenskaya NI; Kostanyan IA; Sherstnev VV; Morozova-Roche LA
    Dement Geriatr Cogn Disord; 2004; 18(2):165-71. PubMed ID: 15211072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-n oligomers as therapeutic targets of Alzheimer's disease.
    Ono K; Yamada M
    J Neurochem; 2011 Apr; 117(1):19-28. PubMed ID: 21244429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Number of Plasma B Cells Producing Autoantibodies Against Aβ42 Protofibrils in Alzheimer's Disease.
    Söllvander S; Ekholm-Pettersson F; Brundin RM; Westman G; Kilander L; Paulie S; Lannfelt L; Sehlin D
    J Alzheimers Dis; 2015; 48(1):63-72. PubMed ID: 26401929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.